INTERNATIONAL PATENT: SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. FILES APPLICATION FOR "METHOD FOR TREATING DYSLIPIDEMIA WITH ANGIOPOIETIN-LIKE 3 (ANGPTL3) -TARGETED RNAI AGENTS"

GENEVA, Oct. 3 -- SHANGHAI ARGO BIOPHARMACEUTICAL CO., LTD. (J2026, Room 1_203, 337 Shahe Road, Jiangqiao TownJiading District, Shanghai 201803) filed a patent application (PCT/CN2025/084552) for "METHOD FOR TREATING DYSLIPIDEMIA WITH ANGIOPOIETIN-LIKE 3 (ANGPTL3) -TARGETED RNAI AGENTS" on Mar 25, 2025. With publication no. WO/2025/201277, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHU, Dongxu (Room 201, No.24, Lane 535, Qingnian Road, Qiuai Town, Yinzhou DistrictNingbo, Zhejiang 315100), SHAO, Pengcheng Patrick (631...